Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04260009
Status:
WITHDRAWN
Last Update Posted:
2020-03-05
First Post:
2020-01-22
Brief Title:
Pharmacokinetics Safety and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK Anaplastic Large Cell Lymphoma Inflammatory Myofibroblastic Tumors or Other Solid Tumors
Sponsor:
Takeda
Organization:
Takeda
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumors |
| Anaplastic Lymphoma Kinase Positive ALK Anaplastic Large Cell Lymphoma |
| Inflammatory Myofibroblastic Tumors |
Keywords:
| Name | View |
|---|---|
| Drug Therapy | View |